Literature DB >> 19156501

Immunoglobulin M 'Flare' after rituximab-associated acute tubular necrosis in Waldenström's macroglobulinemia.

Hassane Izzedine1, Edward Bourry2, Lucile Amrouche2, Isabelle Brocheriou3, Madalina Uzunov4, Frederique Capron3, Veronique Leblond4, Gilbert Deray2.   

Abstract

Waldenström's macroglobulinemia (WM) is a low-grade lymphoplasmacytic lymphoma characterized by a circulating monoclonal IgM. Renal involvement in classical cases of WM is rare, and the pathological hallmark finding in the renal biopsy specimen is a thrombotic microangiopathy. We report the case of a 69-year-old man with the diagnosis of WM for 3 months before he presented with acute renal failure (ARF). A renal biopsy performed suggested the diagnosis of acute tubular necrosis. The diagnosis of ARF related to IgM flare after Rituximab therapy was made.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19156501     DOI: 10.1007/s12185-008-0244-7

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  21 in total

1.  Initial immunoglobulin M 'flare' after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia: an Eastern Cooperative Oncology Group Study.

Authors:  Irene M Ghobrial; Rafael Fonseca; Philip R Greipp; Emily Blood; Montserrat Rue; David H Vesole; Morie A Gertz
Journal:  Cancer       Date:  2004-12-01       Impact factor: 6.860

2.  Influence of blood rheology on intrarenal blood flow distribution.

Authors:  K M McDonald
Journal:  Am J Physiol       Date:  1976-05

Review 3.  The spectrum of IgM monoclonal gammopathy in 430 cases.

Authors:  R A Kyle; J P Garton
Journal:  Mayo Clin Proc       Date:  1987-08       Impact factor: 7.616

4.  Waldenström macroglobulinemia presenting as a renal or perirenal mass: clinical and radiographic features.

Authors:  D F Moore; L A Moulopoulos; M A Dimopoulos
Journal:  Leuk Lymphoma       Date:  1995-04

5.  Renal pathology of Waldenström's macroglobulinaemia with monoclonal antiglomerular antibodies and nephrotic syndrome.

Authors:  F D Lindström; J Hed; S Eneström
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

6.  Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom's macroglobulinemia: a two-institution study.

Authors:  M Björkholm; E Johansson; D Papamichael; F Celsing; J Matthews; T A Lister; A Z S Rohatiner
Journal:  Semin Oncol       Date:  2003-04       Impact factor: 4.929

7.  Acute renal failure in primary macroglobulinemia with small-molecule IgM.

Authors:  J Matsumoto; T Yasaka; I Ohya; H Ohtani
Journal:  Arch Intern Med       Date:  1985-05

8.  Cast nephropathy in a case of Waldenström's macroglobulinemia.

Authors:  Jorge Isaac; Guillermo A Herrera
Journal:  Nephron       Date:  2002-07       Impact factor: 2.847

9.  Giant kidneys in Waldenström's macroglobulinemia.

Authors:  M E Grossman; M J Bia; M I Goldwein; G Hill; M Goldberg
Journal:  Arch Intern Med       Date:  1977-11

Review 10.  Renal involvement in hematological disorders: monoclonal immunoglobulins and nephropathy.

Authors:  P M Ronco; B Mougenot; G Touchard; J L Preud'homme; P Aucouturier
Journal:  Curr Opin Nephrol Hypertens       Date:  1995-03       Impact factor: 2.894

View more
  1 in total

Review 1.  Waldenstrom Macroglobulinemia: Tailoring Therapy for the Individual.

Authors:  Morie A Gertz
Journal:  J Clin Oncol       Date:  2022-06-14       Impact factor: 50.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.